Results for “”

Entry Author Date Location
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases 08/26/20 Boston
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout 08/26/20 San Diego
FDA Rejects Tricida Chronic Kidney Disease Drug, More Data Needed 08/25/20 San Francisco
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Yumanity to Merge With Proteostasis to Advance Neuro Drug Pipeline 08/24/20 Boston
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts 08/20/20 National
Alzheon Lands $47M to Take Another Shot at a Pivotal Alzheimer’s Test 08/20/20 Boston
FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data 08/19/20 National
J&J Boosts Autoimmune Disease Drug Pipeline With $6.5B Momenta Buyout 08/19/20 New York
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program’s End 08/18/20 San Francisco
Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug 08/18/20 San Francisco
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor 08/17/20 Boston
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Sanofi Reaches $3.68B Deal to Buy Principia and Partnered MS Drug 08/17/20 Europe
Advisory Body Backs MesoBlast Therapy for Transplant Complication 08/14/20 New York
CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears 08/14/20 Europe
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor 08/12/20 New York
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia 08/12/20 San Francisco
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections 08/12/20 Europe
Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political 08/12/20 National
Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup 08/11/20 San Diego
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials 08/11/20 National
Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 08/10/20 Boston
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Page 2 of 1973 « previous page · next page »